Notice: Use of undefined constant REQUEST_URI - assumed 'REQUEST_URI' in /customers/f/d/b/newscabal.co.uk/httpd.www/wp-content/themes/twentynineteen/functions.php on line 73 Roche: FDA approves drug combo Venclexta plus Gazyva for previously untreated chronic lymphocytic leukemia - NEWSCABAL

Roche: FDA approves drug combo Venclexta plus Gazyva for previously untreated chronic lymphocytic leukemia


Swiss drugmaker Roche’s logo is seen at their headquarters in Basel, Switzerland January 28, 2016. REUTERS/Arnd Wiegmann

ZURICH (Reuters) – Roche said on Thursday that the U.S. Food and Drug Administration had approved a treatment using its drugs Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukemia.

“Venclexta plus Gazyva is the only chemotherapy-free option of fixed duration that provides durable responses to help people live longer without progression of their disease, compared to a standard-of-care,” Roche’s Chief Medical Officer Sandra Horning said in a statement.

Reporting by Brenna Hughes Neghaiwi; Editing by Michelle Martin



READ SOURCE

READ  Parkinson’s disease symptoms: Three bowel problems that can signal condition

Leave a comment

Your email address will not be published. Required fields are marked *